Lance Baldo, Chief Medical Officer at Adaptive Biotechnologies Corp (ADPT), sold 99,450 shares at $33.85 ($3.4M) on 2020-05-06, disclosed to the SEC on 2020-05-08.
Open-market sale of $3.4M ADPT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.85 | 49,450 | $1.7M | 49.7% |
| 2 | $33.85 | 49,450 | $1.7M | 49.7% |
| 3 | $34.55 | 550 | $19K | 0.6% |
| Total | $33.85 avg | 99,450 | $3.4M | 100% |
| Filing → |
| ADPT | SELL | 2021-04-16 | $89K | — | Filing → |
| ADPT | SELL | 2021-01-29 | $4.7M | — | Filing → |
| ADPT | SELL | 2020-12-09 | $442K | — | Filing → |